Department of Justice January 2019 – Federal Register Recent Federal Regulation Documents

Notice Pursuant to the National Cooperative Research and Production Act of 1993-ODPI, Inc.
Document Number: 2019-00489
Type: Notice
Date: 2019-01-31
Agency: Antitrust Division, Department of Justice
Schedules of Controlled Substances: Placement of MAB-CHMINACA in Schedule I
Document Number: 2019-00254
Type: Rule
Date: 2019-01-29
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration places N-(1-amino-3,3- dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (MAB-CHMINACA; ADB-CHMINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle MAB-CHMINACA.